News
All NewsPress ReleasesProduct Approvals and Launches
Video
All Video TypesAJMC TVGuidelinesInsightsOnLocationPayer PerspectivesPeer ExchangePost Conference PerspectivesStakeholder Summit
Podcasts
Journals
All JournalsThe American Journal of Managed CarePopulation Health, Equity & OutcomesEvidence-Based OncologyAbout Supplements and Featured PublicationsSupplements and Featured Publications IssuesSubmit a Manuscript
More
Conferences
Conference CoverageConference ListingPost Conference Perspectives
Events
Institute for Value-Based MedicinePatient-Centered Oncology Care
Resources
Interactive ToolsFormulary CentralClinical SpotlightMicrositesSponsored Content
CE
About AJMC
AJMC StaffAnniversarySeema Sonnad AwardStrategic Alliance Partners

Subscribe

  • News
  • Video
  • Podcasts
  • Journals
  • Conferences
  • Events
  • Resources
  • CE
  • About AJMC
  • Subscribe
  • Biosimilars
  • Cardiorenalmetabolic
    • Cardiomyopathy
    • Cardiovascular
    • Chronic Kidney Disease
    • Diabetes
    • Heart Failure
    • Type 1 Diabetes
  • Dermatology
    • Alopecia
    • Atopic Dermatitis
    • Psoriasis
  • Gastroenterology
  • Hematology
    • ALL/AML
    • CLL/SLL
    • GVHD
    • Hemophilia
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
    • Non-Hodgkin Lymphoma
    • Rare Blood
  • Hepatology
    • Liver
    • MASH
  • Immunology
    • Allergy
    • Autoimmune
    • Inflammation
    • Lupus
    • Myasthenia Gravis
    • Rheumatoid Arthritis
  • Infectious Disease
    • COVID-19
    • HIV
    • RSV
    • Vaccines
  • Mental Health
    • Major Depressive Disorder
    • Sleep
  • Neurology
    • Duchenne Muscular Dystrophy
    • Epilepsy
    • Multiple Sclerosis
    • Parkinson Disease
  • Obesity
  • Oncology
    • Breast Cancer
    • Cholangiocarcinoma
    • Colorectal Cancer
    • Immuno-Oncology
    • Liver Cancer
    • Non–Small Cell Lung Cancer
    • Ovarian Cancer
    • Prostate Cancer
    • Skin Cancer
    • Small Cell Lung Cancer
    • Soft Tissue Sarcoma
  • Ophthalmology
  • Pulmonology
    • COPD
    • Pulmonary Arterial Hypertension
  • Rare Disease
    • Spinal Muscular Atrophy
  • Respiratory
    • Asthma
    • Pulmonary Fibrosis
  • Rheumatology
  • Women's Health
  • Biosimilars
  • Center on Health Equity & Access
  • Digital Health
  • Formulary
  • Gene Therapy
  • Guidelines
  • Health Care Administration
    • Employers
    • Medicare
    • Reimbursement
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Population Health
  • Product Approvals and Launches
  • Technology
  • Value-Based Care
Spotlight -
Free In-Person Regional Events Focused on Oncology and Population Health
Advertisement

David R. Holmes Jr, MD

Advertisement

Articles by David R. Holmes Jr, MD

Clinical and Economic Outcomes After Introduction of Drug-Eluting Stents

ByCharanjit S. Rihal, MD, MBA,James L. Ryan, MHA,Mandeep Singh, MBBS,Ryan J. Lennon, MS,John F. Bresnahan, MD,Juliette T. Liesinger, BA,Bernard J. Gersh, MBChB, DPhil,Henry H. Ting, MD, MBA,David R. Holmes Jr, MD,Kirsten Hall Long, PhD
August 11th 2010

Introduction of drug-eluting stents resulted in improved clinical outcomes for patients and reduced overall procedural costs.

Economic and Clinical Outcomes of a Physician-led Continuous Quality Improvement Intervention in the Delivery of Percutaneous Coronary Intervention

ByCharanjit S. Rihal, MD, MBA,Celia C. Kamath, PhD,David R. Holmes Jr, MD,M. Katherine Reller, RN,Stephanie S. Anderson, BS,Erin K. McMurtry, MS,Kirsten Hall Long, PhD
August 1st 2006
Advertisement

Latest Updated Articles

  • Economic and Clinical Outcomes of a Physician-led Continuous Quality Improvement Intervention in the Delivery of Percutaneous Coronary Intervention
    Economic and Clinical Outcomes of a Physician-led Continuous Quality Improvement Intervention in the Delivery of Percutaneous Coronary Intervention

    Published: August 1st 2006 | Updated:

  • Clinical and Economic Outcomes After Introduction of Drug-Eluting Stents
    Clinical and Economic Outcomes After Introduction of Drug-Eluting Stents

    Published: August 11th 2010 | Updated:



Advertisement
Advertisement

Trending on AJMC

1

Howard A. “Skip” Burris, III, MD: An Oncology Pioneer Reflects on Patients, Progress, and Purpose

2

New Bill Makes CMS Enforcer in PBM, Pharmacy Relationship: A Q&A With Jesse Dresser, Esq

3

Faricimab Safe, Effective for Use in Treating nAMD in Treatment-Naive Eyes

4

Asundexian Cuts Recurrent Stroke Risk Without More Bleeding: Mukul Sharma, MD, MSc

5

Debunking Myths to Boost Clinical Trial Enrollment Diversity: Susan Vadaparampil, PhD, MPH

Brand Logo
  • About
  • Contact
  • Editorial Boards
  • Advertise
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text